The publicly listed company Propanc Biopharma plans to acquire 100 million dollars in Ethereum

2025-09-02 21:05:53

Collection

ChainCatcher news, biopharmaceutical company Propanc Biopharma (NASDAQ: PPCB) announced plans to acquire $100 million worth of Ethereum in the next 12 months.

The company stated that this move will enhance its corporate strategy in various areas including cryptocurrency investment, drug development, and asset acquisition.

(Source Link)

Risk warning

2026-04-17 11:58

The Ethereum NFT marketplace Foundation has failed to sell and announced its permanent closure, ceasing all operations

2026-04-17 10:38

Data: The total net inflow of the Ethereum spot ETF yesterday was $67.847 million, continuing a 5-day net inflow

2026-04-16 12:04

UK asset management firm Legal & General has put over £50 billion of funds on the blockchain through the Calastone network

2026-04-16 08:38